The gut and energy balance: visceral allies in the obesity wars
MK Badman, JS Flier - Science, 2005 - science.org
In addition to digesting and assimilating nutrients, the intestine and associated visceral
organs play a key sensing and signaling role in the physiology of energy homeostasis. The …
organs play a key sensing and signaling role in the physiology of energy homeostasis. The …
Gastrointestinal hormones and food intake
AD Strader, SC Woods - Gastroenterology, 2005 - Elsevier
Despite dramatic fluctuations in calorie intake, animals maintain a very stable body weight.
The reason is that energy intake and expenditure are precisely matched. Long-term …
The reason is that energy intake and expenditure are precisely matched. Long-term …
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial
K Wynne, AJ Park, CJ Small, M Patterson, SM Ellis… - Diabetes, 2005 - Am Diabetes Assoc
This study investigated the effect of subcutaneously administered oxyntomodulin on body
weight in healthy overweight and obese volunteers. Participants self-administered saline or …
weight in healthy overweight and obese volunteers. Participants self-administered saline or …
[HTML][HTML] Hormonal regulation of food intake
Our knowledge of the physiological systems controlling energy homeostasis has increased
dramatically over the last decade. The roles of peripheral signals from adipose tissue …
dramatically over the last decade. The roles of peripheral signals from adipose tissue …
Peptide YY3–36 and Glucagon-Like Peptide-17–36 Inhibit Food Intake Additively
NM Neary, CJ Small, MR Druce, AJ Park… - …, 2005 - academic.oup.com
Peptide YY (PYY) and glucagon like peptide (GLP)-1 are cosecreted from intestinal L cells,
and plasma levels of both hormones rise after a meal. Peripheral administration of PYY3–36 …
and plasma levels of both hormones rise after a meal. Peripheral administration of PYY3–36 …
Biologic actions and therapeutic potential of the proglucagon-derived peptides
DJ Drucker - Nature clinical practice endocrinology & metabolism, 2005 - nature.com
The actions of the structurally related proglucagon-derived peptides (PGDPs)—glucagon,
glucagon-like peptide (GLP)-1 and GLP-2—are focused on complementary aspects of …
glucagon-like peptide (GLP)-1 and GLP-2—are focused on complementary aspects of …
Pharmacotherapy for obesity
LL Ioannides-Demos, J Proietto, JJ McNeil - Drugs, 2005 - Springer
Pharmacotherapy for the management of obesity is primarily aimed at weight loss, weight
loss maintenance and risk reduction, and has included thyroid hormone, amphetamines …
loss maintenance and risk reduction, and has included thyroid hormone, amphetamines …
Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes
I Chapman, B Parker, S Doran, C Feinle-Bisset… - Diabetologia, 2005 - Springer
Aims/hypothesis Long-term trials in insulin-treated subjects with type 2 diabetes have shown
that adjunctive treatment with the amylin analogue pramlintide reduces HbA 1 c levels and …
that adjunctive treatment with the amylin analogue pramlintide reduces HbA 1 c levels and …
Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor
E Ghigo, F Broglio, E Arvat, M Maccario… - Clinical …, 2005 - Wiley Online Library
Ghrelin, an acylated peptide produced predominantly by the stomach, has been discovered
to be a natural ligand of the growth hormone secretagogue receptor type 1a (GHS‐R1a) …
to be a natural ligand of the growth hormone secretagogue receptor type 1a (GHS‐R1a) …